Malaria Vaccines

Research for development of a malaria vaccine is currently underway to find an effective modality to control and eliminate the transmission of malaria. To date, no vaccine has been found to be efficacious in fighting against malaria. Here is the latest research on malaria vaccines.

July 6, 2020

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19

Expert Review of Clinical Immunology
Sebastian E SattuiJeffrey A Sparks
July 4, 2020

The Role of Mass Drug Administration of Antimalarials

The American Journal of Tropical Medicine and Hygiene
Pedro L Alonso
July 8, 2020

Enhanced health facility surveys to support malaria control and elimination across different transmission settings in The Philippines

MedRxiv : the Preprint Server for Health Sciences
Ralph Atienza ReyesF. E. J. Espino
July 2, 2020

The E3 ubiquitin ligase MARCH1 regulates antimalaria immunity through interferon signaling and T cell activation

Proceedings of the National Academy of Sciences of the United States of America
Jian WuXin-Zhuan Su
July 3, 2020

Repurposing old drugs to fight multidrug resistant cancers

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
Jelena DinićIvanka Tsakovska
July 1, 2020

Covid-19: current knowledge, disease potential, prevention and clinical advances

Turkish Journal of Biology = Türk Biyoloji Dergisi
Aftab AlamRomana Ishrat
July 1, 2020
Open Access

Structure of Full Length Plasmodium Myosin A and its light chain PfELC, dual targets against malaria parasite pathogenesis

BioRxiv : the Preprint Server for Biology
D. MoussaouiAnne Houdusse
July 3, 2020

Bioprospecting of Nitrogenous Heterocyclic Scaffolds with Potential Action for Neglected Parasitosis: A Review

Current Pharmaceutical Design
Sonaly Lima AlbinoRicardo Olímpio de Moura
July 3, 2020

A new prenylated coumestan from the roots of Campylotropis hirtella

Journal of Asian Natural Products Research
Yang LiBei Jiang
July 3, 2020

Modulation of triple artemisinin-based combination therapy pharmacodynamics by Plasmodium falciparum genotype

BioRxiv : the Preprint Server for Biology
M. R. AnsbroRichard T. Eastman
July 8, 2020

Fungal Metabolite Asperaculane B Inhibits Malaria Infection and Transmission

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Guodong NiuJun Li
July 3, 2020

Combined CADD and Virtual Screening to Identify Novel Nonpeptidic Falcipain-2 Inhibitors

Current Computer-aided Drug Design
Trisha RajguruMahendra Kumar Modi
July 8, 2020

In-silico analysis of Calcium Dependent Protein Kinase 6 of Cryptosporidium parvum through molecular modeling, docking, and dynamics simulation study

Journal of Biomolecular Structure & Dynamics
Ajit Kumar DhalRajani Kanta Mahapatra
July 6, 2020

Experimental transmission of Plasmodium malariae to Anopheles gambiae

The Journal of Infectious Diseases
Yudi T PinillaCOMAL Study Group

Sign up to follow this feed and discover related papers.

Related Feeds

AIDS Malignancies

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Amoebiasis, infection by the protozoan parasite Entamoeba histolytica, remains a global health problem, despite the availability of effective treatment. Here is the latest research.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

© 2020 Meta ULC. All rights reserved